載入...
Effect of bosentan is correlated with MMP-9/TIMP-1 ratio in bleomycin-induced pulmonary fibrosis
Pulmonary fibrosis (PF) is a life-threatening non-tumorous disease characterized by progressive fibrosis and worsening lung function. Various drugs, such as bleomycin, can contribute to lung injury and PF, with lung injury potentially occurring in 10% of bleomycin users. Bleomycin is the most common...
Na minha lista:
| 發表在: | Biomed Rep |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351104/ https://ncbi.nlm.nih.gov/pubmed/28357073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.832 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|